The Prevalence of Headache in Crohn’s Disease: Single-Center Experience

Table 3

Detailed comparison of different parameters between patients with and without headache in Crohn’s disease group.

	Headache
	No ()	Yes ()
	(%)	(%)
Smoking	3 (18.7%)	11 (31.4%)	0.5
Extraintestinal involvement	3 (18.7%)	13 (37.1%)	0.3
Site of involvement in Crohn’s disease
Ileal	6 (37.5%)	17 (48.6%)	0.6
Ileocolonic	8 (50%)	16 (45.7%)
Colonic	2 (12.5%)	2 (5.7%)
Types of Crohn’s disease
Inflammatory	10 (62.5%)	22 (62.9%)	0.5
Fistulating	2 (12.5%)	8 (22.9%)
Fibrostenotic	4 (25%)	5 (14.3%)
Medications used
Mesalazine	16 (100%)	34 (97.1%)	1
Steroid	4 (25%)	5 (14.3%)	0.4
Azathioprine	10 (62.5%)	17 (48.6%)	0.5
Anti-TNF	2 (12.5%)	6 (17.1%)	1
CDAI (Mean ± SD)	73.88 ± 36.99	69.14 ± 33.46	0.6

Mean ± SD: mean ± standard deviation; CDAI: Crohn’s disease activity index.